Cargando…
Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese Volunteers
BACKGROUND: Fentanyl buccal tablet (FBT; FENTORA®, Cephalon, Inc., Frazer, PA, USA) is indicated in the US for breakthrough pain in patients with cancer who are already receiving and are tolerant to around-the-clock opioid therapy for underlying persistent cancer pain. For each individual patient, F...
Autores principales: | Darwish, Mona, Tempero, Kenneth, Jiang, John G, Simonson, Philip G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Inc
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773523/ https://www.ncbi.nlm.nih.gov/pubmed/19915709 http://dx.doi.org/10.1111/j.1753-5174.2008.00009.x |
Ejemplares similares
-
Dose Proportionality of Fentanyl Buccal Tablet in Healthy Japanese Volunteers
por: Darwish, Mona, et al.
Publicado: (2008) -
Extent of Fentanyl Accumulation Following Multiple Doses of Fentanyl Buccal Tablet 400 µg in Healthy Japanese Volunteers
por: Darwish, Mona, et al.
Publicado: (2008) -
Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain: Pharmacokinetics of Buccal Mucosa Delivery and Clinical Efficacy
por: Darwish, Mona, et al.
Publicado: (2010) -
Predicting tolerability of high-dose fentanyl buccal tablets in cancer patients
por: Kwon, Mi-Young, et al.
Publicado: (2023) -
Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain
por: Darbà, Josep, et al.
Publicado: (2013)